- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
AI-Led Diabetes Prevention Program as an Effective Alternative to Human Coaching: JAMA

Researchers have found in a new study that among adults with prediabetes and overweight or obesity, a fully automated, AI-led Diabetes Prevention Program (DPP) may serve as a viable and effective alternative to traditional DPPs led by human coaches, offering scalable and accessible diabetes prevention support. The study was published in JAMA by Nestoras M. and colleagues.
The main goal of the study was to assess whether referral to an entirely AI-run DPP lifestyle program was noninferior to referral to an entirely human-run DPP in terms of improving weight loss, glycemia, and physical activity in adults with prediabetes.
This was a parallel group, pragmatic, noninferiority randomized controlled clinical trial performed from October 11, 2021, to December 16, 2024, at two research sites in the United States: in Baltimore, Maryland, and in Reading, Pennsylvania. Patients were recruited for this study when they were at least 18 years of age with either prediabetes and overweight or obese.
A total of 368 participants were included in the analysis. The median age was 58 years (interquartile range [IQR], 50-65 years), and the participants were comprised of 71% female, 27% Black, 6% Hispanic, and 61% White individuals. The median body mass index (BMI) was 32.3 (IQR, 28.5-37.1). The participants were equally randomly assigned to a study group undergoing an AI-driven DPP through a mobile app using a digital scale connected by Bluetooth or a remote human coach-led DPP. The study groups were both independent of the research group.
Key Findings
• The rate of initiation of the AI-led DPP was 93.4% (171 of 183) compared with 82.7% (153 of 185) for the human-led DPP.
• The rate of achieving the composite primary outcome was 31.7% (58 of 183) for the AI-led DPP and 31.9% (59 of 185) for the human-led DPP.
• The risk difference was -0.2% with a one-sided 95% CI of -8.2%, which met the criterion for noninferiority.
• A composite endpoint measured at 12 months and defined as the maintenance of hemoglobin A1c (HbA1c) values of less than 6.5% during the entire study period and either of the following: at least 5% of absolute weight loss; at least 4% of absolute weight loss plus at least 150 minutes of physical activity per week; and/or an absolute decrease of at least 0.2% of HbA1c values in comparison with baseline was the primary outcome.
• Noninferiority had been prespecified with the lower bound of the one-sided 95% confidence limit of the risk difference no longer than −15%.
In a group of adults with prediabetes and overweight or obesity, referral to a completely automated AI-powered Diabetes Prevention Program was found to be noninferior to a human-conducting program for achieving significant improvement in weight, physical activity, and glycemic control. These findings establish the inclusion of AI-driven lifestyle interventions in the panoply of strategies for the prevention of diabetes in the general public.
Reference:
Mathioudakis N, Lalani B, Abusamaan MS, et al. An AI-Powered Lifestyle Intervention vs Human Coaching in the Diabetes Prevention Program: A Randomized Clinical Trial. JAMA. 2025;334(23):2079–2089. doi:10.1001/jama.2025.19563
Dr Riya Dave has completed dentistry from Gujarat University in 2022. She is a dentist and accomplished medical and scientific writer known for her commitment to bridging the gap between clinical expertise and accessible healthcare information. She has been actively involved in writing blogs related to health and wellness.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751

